Specialty Pharma Journal Specialty, Precision & Technology
TUCSON, Ariz., July 30, 2018 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received U.S. Food and Drug Administration (FDA) approval for the cobas® HPV Test to be used as the first-line screening test for cervical cancer in women 25 and older using cervical specimens …
Tag Archives: diagnosis
August, 2018
June, 2018
-
6 June
Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma
WASHINGTON, June 5, 2018 /PRNewswire/ — Researchers at Exact Sciences Corp. (Nasdaq: EXAS) and Mayo Clinic announced significant progress toward developing a panel of novel, blood-based, DNA biomarkers that could accurately detect hepatocellular carcinoma (HCC), the most common cancer that originates in the liver.1 The researchers detailed their findings during …
January, 2018
-
31 January
SkylineDx and Mayo Clinic Enter Strategic Collaboration to Develop Diagnostic Tests for Melanoma
ROTTERDAM, Netherlands, Jan. 31, 2018 /PRNewswire/ — SkylineDx today announced a strategic collaboration with Mayo Clinic to develop novel diagnostic tests which will improve clinical decision making for melanoma patients. For SkylineDx, the collaboration with the renowned Mayo Clinic is an important milestone as it allows the company to develop …
December, 2017
-
18 December
Early Diagnosis Can Save Babies’ Lives: A Guide to Severe Combined Immunodeficiency Disease (SCID)
A new review provides guidance on a deadly, but rare, disease that is potentially curable if identified early. Severe combined immunodeficiency disease (SCID), known as the “bubble boy disease” in the 1970s, is treatable with a stem cell transplant, gene therapy and other treatments if identified at birth or soon …
-
18 December
FDA Approves Ortho Clinical Diagnostics’ HIV Combo Test on Immunodiagnostic System
RARITAN, N.J., Dec. 18, 2017 /PRNewswire/ — Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, announced that its VITROS Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS® HIV Combo test) received approval from the U.S. Food and Drug Administration for use on Ortho’s VITROS 3600 Immunodiagnostic …
-
4 December
Study Evaluates Refractory Epilepsy Screening Tool for Lennox-Gastaut Syndrome
DEERFIELD, Ill.–(BUSINESS WIRE)–Lundbeck today presented data at the American Epilepsy Society (AES) Annual Meeting in Washington, D.C. that demonstrates that the Refractory Epilepsy Screening Tool for LGS (REST-LGS) may help healthcare professionals identify patients who may benefit from further clinical evaluation for Lennox-Gastaut syndrome (LGS). The REST-LGS was developed by …
November, 2017
-
29 November
CDC Report Finds Frequency of HIV Testing and Time from Infection to Diagnosis Improve
ATLANTA, Nov. 28, 2017 /PRNewswire-USNewswire/ — A new CDC Vital Signs report published today finds that HIV is being diagnosed sooner after infection than was previously reported. According to the report, the estimated median time from HIV infection to diagnosis was three years in 2015. CDC previously estimated that, in …
-
28 November
Data Confirms Analytical Validity of Veracyte’s Envisia Genomic Classifier for Use in IPF Diagnosis
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (NASDAQ: VCYT) announced that data confirming the analytical validity of the company’s Envisia™ Genomic Classifier have been published online in the journal BMC Pulmonary Medicine. The findings add to the growing body of evidence, including previously reported clinical validity and clinical utility data, supporting the use …
April, 2017
-
17 April
Rates of New Diagnosed Cases of Type 1 and 2 Diabetes on the Rise Among Children, Teens
Rates of new diagnosed cases of type 1 and type 2 diabetes are increasing among youth in the United States, according to a report, Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012, published today in the New England Journal of Medicine. In the United States, 29.1 …
March, 2017
-
17 March
Routine Blood Tests Can Help Measure A Patient’s Future Risk for Chronic Disease, New Study Finds
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City finds that combining information from routine blood tests and age of primary care patients can create a score that measures future risk of chronic disease. This simple risk score, termed the Intermountain Chronic Disease …